Biolyph, LLC
USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, Biolyph ranks #34,493 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 6 technology areas.
- #34,493
- of 49,997 US assignees by volume
- 45th percentile
- by Innovation Score (33.8/100)
- 24.3
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R34493 · US Corporation #34,493 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #34,493/49,997
- PHOTO-FINISH Bioconnect
- CPC-NARROW B01L · 6 areas
- INNOV-THIN 33.8/100
- CLAIMS-DENSE 24.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Bioconnect Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biolyph’s 33.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biolyph
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Biolyph · this assignee 34
Biolyph · this assignee
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biolyph's Innovation Score is 33.8/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biolyph?
Each dot is one of Biolyph’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biolyph’s own 24.3 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Biolyph's grants concentrate
Biolyph, LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2018. By volume, Biolyph sits between Bioconnect Inc. and Bitdrift, Inc..
Biolyph's three-year grant acceleration
Biolyph, LLC shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Biolyph's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bioconnect
Bioconnect Inc.
7 patents
- Biodel
Biodel AG Inc.
7 patents
- Biodyne
Biodyne Co., Ltd.
7 patents
- Bioinvent Interna…
Bioinvent International AB
7 patents
- Biomarck Pharmace…
Biomarck Pharmaceuticals Ltd.
7 patents
- Biorestorative Th…
Biorestorative Therapies, Inc.
7 patents
- Biorest
BIOrest Ltd.
7 patents
- Bitdrift
Bitdrift, Inc.
7 patents
- Biolyph ◀
Biolyph, LLC
7 patents
What this shows Biolyph holds 7 patents at rank #34,443, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biolyph
By rank, the assignees closest to #34,443 in granted patent volume.
- Bioconnect Inc. #34,439 · 7 patents
- Biodel AG Inc. #34,440 · 7 patents
- Biodyne Co., Ltd. #34,441 · 7 patents
- Bioinvent International AB #34,442 · 7 patents
- Biomarck Pharmaceuticals Ltd. #34,444 · 7 patents
- Biorestorative Therapies, Inc. #34,445 · 7 patents
- BIOrest Ltd. #34,446 · 7 patents
- Bitdrift, Inc. #34,447 · 7 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Biolyph's primary technology class.
- The Regents of the University of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson and Company 193 in class
- Bio-Rad Laboratories, Inc. 174 in class
- President and Fellows of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Biolyph's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 45th percentile higher than 45% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 28.6% |
| 2018 | 1 | 14.3% |
| 2019 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2023 | 1 | 14.3% |
| 2025partial year | 1 | 14.3% |
Which technologies does Biolyph, LLC patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Biolyph, LLC's patent record in context - here's where to go next.
- Biolyph, LLC's lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 100% of its portfolio - see every assignee active in that class. Explore B01L
- Ranked #34,493 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Biolyph, LLC against Bioconnect Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.